Home Cart 0 Sign in  

[ CAS No. 367-24-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 367-24-8
Chemical Structure| 367-24-8
Structure of 367-24-8 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 367-24-8 ]

Related Doc. of [ 367-24-8 ]

Alternatived Products of [ 367-24-8 ]
Product Citations

Product Details of [ 367-24-8 ]

CAS No. :367-24-8 MDL No. :MFCD00010221
Formula : C6H5BrFN Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 190.01 Pubchem ID :-
Synonyms :

Calculated chemistry of [ 367-24-8 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 38.5
TPSA : 26.02 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.95 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.71
Log Po/w (XLOGP3) : 2.13
Log Po/w (WLOGP) : 2.6
Log Po/w (MLOGP) : 2.67
Log Po/w (SILICOS-IT) : 2.25
Consensus Log Po/w : 2.27

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.85
Solubility : 0.266 mg/ml ; 0.0014 mol/l
Class : Soluble
Log S (Ali) : -2.31
Solubility : 0.935 mg/ml ; 0.00492 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.17
Solubility : 0.128 mg/ml ; 0.000673 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.3

Safety of [ 367-24-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 367-24-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 367-24-8 ]

[ 367-24-8 ] Synthesis Path-Downstream   1~12

  • 1
  • [ 28563-38-4 ]
  • [ 367-24-8 ]
  • [ 51618-30-5 ]
  • 2
  • [ 367-24-8 ]
  • [ 140-89-6 ]
  • [ 51618-30-5 ]
  • 3
  • [ 367-24-8 ]
  • [ 883500-73-0 ]
  • 4
  • [ 755039-55-5 ]
  • [ 367-24-8 ]
  • [ 1021853-59-7 ]
YieldReaction ConditionsOperation in experiment
20% Stage 1 - (7R)-2-[(4-Bromo-2-fluorophenyl)amino]-8-cyclopentyl-7-ethyl-5-methyl-7,8- dihydropteridin-6(5H)-oneTo a suspension of 4-bromo-2-fluoro-phenylamine (388mg, 2.04mmol) in ethanol (2.5ml) and water (10ml) was added concentrated HCI (0.26ml) and intermediate A (300mg, 1.02mmol). The mixture was heated at 800C for 18 hours, cooled and the solvent was removed under reduced pressure. The residue was diluted with EtOAc (10ml) and washed with saturated NaHCO3 (2 x 10 ml). The organic layer was dried (MgSO4) and concentrated under reduced pressure. The crude product was purified by column chromatography (20 - 50% EtOAc in heptane) to afford the title product as a yellow oil (90mg, 20%). ESMS: m/z 448, 449, 450 [Br splitting].
  • 5
  • [ 116247-92-8 ]
  • [ 367-24-8 ]
  • [ 1025392-81-7 ]
YieldReaction ConditionsOperation in experiment
A. (4-Bromo-2-fluoro-phenyl)-(l-pyrimidin-2-yl-piperidin-4-yl)-amine: To the mixture of bromoaniline (285 mg, 1.5 mmol) and ketone (266 mg, 1.5 mmol) in MeOH/AcOH (10:1, 5 ml) was added BH3-Py in THF (8M, 188 mul). The mixture was stirred at rt for 2h. The reaction mixture was concentrated and to the residue was added HCl (10%, 10 ml). The resulting mixture was stirred at rt for 30 min., then with cooling, the mixture was adjusted to alkaline with solid Na2CO3 and water. The aq. layer was extracted with EtOAc (5x 30 ml). The EtOAc was dried (Na2SO4) and concentrated. The residue was subjected to ISCO to give the titled compound as a white solid (230 mg).
  • 6
  • [ 367-24-8 ]
  • [ 57002-01-4 ]
  • [ 1400654-22-9 ]
YieldReaction ConditionsOperation in experiment
2.58 g With [1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene](3-chloropyridyl)palladium(ll) dichloride; potassium tert-butylate; In isopropyl alcohol; at 20℃; for 15h;Inert atmosphere; (1) Isopropanol (60 mL) was added to PEPPSI-IPr catalyst (161 mg, 0.24 mmol) and tert-butoxy potassium (2.65 g, 23.6 mmol) under an argon atmosphere, and the mixture was stirred at room temperature for 15 min. To the reaction mixture were added <strong>[57002-01-4]trans-(2-cyclohexylvinyl)boronic acid</strong> (2.00 g, 13.0 mmol) and 4-bromo-2-fluoroaniline (2.24 g, 11.8 mmol) successively and the mixture was stirred at room temperature for 15 hr. Water was added thereto, the mixture was extracted with ethyl acetate, and the organic layer was washed with brine and dried over anhydrous magnesium sulfate. The desiccant was filtered off and the filtrate was concentrated under reduced pressure to afford 4-[(E)-2-cyclohexylethenyl]-2-fluoroaniline as a reddish brown oil (2.58 g).
  • 7
  • [ 98556-31-1 ]
  • [ 367-24-8 ]
  • N-(4-bromo-2-fluorophenyl)-6-iodoquinazolin-4-amine [ No CAS ]
YieldReaction ConditionsOperation in experiment
96% In isopropyl alcohol; at 20 - 80℃; for 2h; General procedure: To a solution of compound 9 (5.8 g, 20 mmol) in 2-propanol was added anilines (22 mmol) at room temperature (r.t.). Then the reaction mixture was heated to 80 C for 2 hours. After the start material was completed, the mixture was filtered through celite, and the cake was washed by 2-propanol, then dried to obtain the desired compounds 10a-10d. N-(4-Bromo-2-fluorophenyl)-6-iodoquinazolin-4-amine (10a): Yield 96%; mp 240-242C; 1H NMR (400MHz, DMSO-d6): δ 12.02 (s, 1H), 9.35 (d, 1H, J=1.5Hz), 8.94 (s, 1H), 8.40 (dd, 1H, J=8.8, 1.6Hz), 7.84-7.76 (m, 2H), 7.61-7.50 (m, 2H).
  • 8
  • [ 367-24-8 ]
  • [ 21080-80-8 ]
  • [ 2043-61-0 ]
  • 1-(4-bromo-2-fluorophenyl)-5-cyclohexyl-4-(cyclopropanecarbonyl)-3-hydroxy-1,5-dihydro-2H-pyrrol-2-one [ No CAS ]
  • 9
  • [ 3132-99-8 ]
  • [ 367-24-8 ]
  • [ 21080-80-8 ]
  • 1-(4-bromo-2-fluorophenyl)-5-(3-bromophenyl)-4-(cyclopropanecarbonyl)-3-hydroxy-1,5-dihydro-2H-pyrrol-2-one [ No CAS ]
  • 10
  • [ 367-24-8 ]
  • [ 337915-79-4 ]
  • 11
  • [ 367-24-8 ]
  • [ 216019-28-2 ]
  • C15H16FN [ No CAS ]
YieldReaction ConditionsOperation in experiment
0.77 g With tetrakis(triphenylphosphine) palladium(0); potassium carbonate; In ethanol; water; toluene;Inert atmosphere; Reflux; Toluene (9 mL), ethanol (6 mL) and water (3 mL) were added into the mixture of M3(0.95 g, 5 mmoi), 3Methyiboronic acid (0.82 g, 5 mmoi) and potassium carbonate (1.73g, 12.5 mmol), stirred with nitrogen replacement for three times. Additional replacementwith nitrogen was performed for three times after 0.3 g of tetraphenylphenylphosphinepalladium was added. Then the reaction was warmed up for reflux reaction overnight.The product was filtered and concentrated, then 20 mL of dichloromethane and 10 mL ofwater were added and stilTed for 10 mitt The liquid was separated and washed with 10mL of water twice, dried with anhydrous sodium sulfate, filtered, concentrated andpurified by column chromatography. 0.77 g of M8 was achieved.
  • 12
  • [ 367-24-8 ]
  • [ 216019-28-2 ]
  • 2-((3-fluoro-3'-isopropyl-[1,1'-biphenyl]-4-yl)carbamoyl)cyclopent-1-ene-1-carboxylic acid [ No CAS ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;